Brisa Rodope Alarcón-Sánchez, Osiris Germán Idelfonso-García, Dafne Guerrero-Escalera, Carolina Piña-Vázquez, Guillermo de Anda-Jáuregui, José Luis Pérez-Hernández, Mireya de la Garza, Francisco García-Sierra, Yesennia Sánchez-Pérez, Rafael Baltiérrez-Hoyos, Verónica Rocío Vásquez-Garzón, Pablo Muriel, Julio Isael Pérez-Carreón, Saúl Villa-Treviño, Jaime Arellanes-Robledo
The worst-case scenario related to alcoholic liver disease (ALD) arises after a long period of exposure to the harmful effect of alcohol consumption along with other hepatotoxics. ALD encompasses a broad spectrum of liver-associated disorders, such as steatosis, steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Based on the chronic administration of different hepatotoxics, including ethanol, sucrose, lipopolysaccharide, and low doses of diethylnitrosamine over a short period, here we aimed to develop a multiple hepatotoxic (MHT)-ALD model in the mouse that recapitulates the human ALD-associated disorders...
April 13, 2024: Biochemical Pharmacology